CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) is seeing a dip in trading today, but over the last month this cannabis powerhouse has added more than a $1.30 in price and since the Spring TWMJF has added more than $4.

TWMJF was profitable through the first three quarters of fiscal 2017 and only wound up losing money for the year because of acquisition-related expenses. Furthermore, acquisitions has been a nice way for the company to have an advantage over its peers and reach more parts of the cannabis marketplace. Also, TWMJF holds an advantage over its peers in terms of production capacity and readiness. It’s also one of just a small handful of Canadian growers that’s been given the green light to export dried cannabis to foreign markets such as Germany, where medical cannabis is also legal.

CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) is one of the bigger growers. The company produces and sells medical marijuana in Canada. It offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. It also sells its products through online.

According to company materials, “Tweed is the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.”

Also from their materials, “Bedrocan is the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.”

Find out when $TWMJF stock reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

In recent news, on October 5, Valens GroWorks Corp, the parent company of Valens Agritech Ltd., announced that it signed a supply and sales agreement with TWMJF. This means that Valens’ products will be added to TWMJF’s CraftGrow distribution network. For a little background here, CraftGrow is a distribution program that is designed to accelerate speed to market for newly licensed cannabis producers.

“We welcome Valens to the Canopy Growth family and look forward to collaborating with their team to provide a steady and high-quality source of cannabis products to increase product variety for our customers.”

Now owning a market cap of $1.73B, TWMJF is one of the brightest Canadian cannabis companies out there. TWMJF is pulling in trailing 12-month revenues of $48.8M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 127.3%. We will update the story again soon as developments transpire. Sign-up for continuing coverage on shares of $TWMJF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $TWMJF, either long or short, and we have not been compensated for this article.

Sign Up for our 100% FREE Oracle Dispatch Newsletter